Stay updated on Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The record describes a completed Phase I/II study of pembrolizumab for relapsed or refractory CD19+ lymphomas after CAR T-cell therapy, including eligibility criteria, study design, outcomes, and study documents.
    Difference
    44%
    Check dated 2026-11-08T14:59:27.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s footer revision changed from v3.7.2 to v3.8.0. The displayed study record remains a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-11-01T16:02:19.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A site-wide notice announces updates to NIH websites and says agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T15:17:22.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:00:41.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:00:36.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page instead of showing the study record details. Access to the study information is blocked, leaving only site chrome and footer visible.
    Difference
    18%
    Check dated 2026-09-20T20:36:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.